Logo image of AXE.CA

ACCELEWARE LTD (AXE.CA) Stock Fundamental Analysis

TSX-V:AXE - TSX Venture Exchange - CA00433V1085 - Common Stock - Currency: CAD

0.095  0 (0%)

Fundamental Rating

2

AXE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 63 industry peers in the Software industry. AXE has a bad profitability rating. Also its financial health evaluation is rather negative. AXE is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

AXE had positive earnings in the past year.
In the past year AXE has reported a negative cash flow from operations.
In the past 5 years AXE reported 4 times negative net income.
In the past 5 years AXE always reported negative operating cash flow.
AXE.CA Yearly Net Income VS EBIT VS OCF VS FCFAXE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

AXE's Return On Assets of 879.85% is amongst the best of the industry. AXE outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 879.85%
ROE N/A
ROIC N/A
ROA(3y)83.08%
ROA(5y)23.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AXE.CA Yearly ROA, ROE, ROICAXE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K

1.3 Margins

AXE's Profit Margin of 46.07% is amongst the best of the industry. AXE outperforms 95.24% of its industry peers.
The Operating Margin of AXE (57.70%) is better than 100.00% of its industry peers.
Industry RankSector Rank
OM 57.7%
PM (TTM) 46.07%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AXE.CA Yearly Profit, Operating, Gross MarginsAXE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

0

2. Health

2.1 Basic Checks

AXE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AXE remains at a similar level compared to 1 year ago.
AXE has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AXE is higher compared to a year ago.
AXE.CA Yearly Shares OutstandingAXE.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
AXE.CA Yearly Total Debt VS Total AssetsAXE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

AXE has an Altman-Z score of -151.30. This is a bad value and indicates that AXE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -151.30, AXE is doing worse than 87.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -151.3
ROIC/WACCN/A
WACC9.33%
AXE.CA Yearly LT Debt VS Equity VS FCFAXE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M

2.3 Liquidity

AXE has a Current Ratio of 0.07. This is a bad value and indicates that AXE is not financially healthy enough and could expect problems in meeting its short term obligations.
AXE has a worse Current ratio (0.07) than 90.48% of its industry peers.
A Quick Ratio of 0.07 indicates that AXE may have some problems paying its short term obligations.
AXE has a worse Quick ratio (0.07) than 90.48% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
AXE.CA Yearly Current Assets VS Current LiabilitesAXE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 192.41% over the past year.
Looking at the last year, AXE shows a very strong growth in Revenue. The Revenue has grown by 2465.36%.
The Revenue has been growing by 29.19% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)192.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.98%
Revenue 1Y (TTM)2465.36%
Revenue growth 3Y90.85%
Revenue growth 5Y29.19%
Sales Q2Q%888.99%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AXE.CA Yearly Revenue VS EstimatesAXE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.75, the valuation of AXE can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of AXE indicates a rather cheap valuation: AXE is cheaper than 96.83% of the companies listed in the same industry.
AXE is valuated cheaply when we compare the Price/Earnings ratio to 27.48, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 4.75
Fwd PE N/A
AXE.CA Price Earnings VS Forward Price EarningsAXE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

95.24% of the companies in the same industry are more expensive than AXE, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.92
AXE.CA Per share dataAXE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AXE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACCELEWARE LTD

TSX-V:AXE (7/17/2025, 7:00:00 PM)

0.095

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-22 2025-05-22
Earnings (Next)08-14 2025-08-14
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners10.95%
Ins Owner ChangeN/A
Market Cap11.26M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.75
Fwd PE N/A
P/S 2
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 3.92
EPS(TTM)0.02
EY21.05%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.05
BVpS-0.05
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 879.85%
ROE N/A
ROCE -89.52%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 57.7%
PM (TTM) 46.07%
GM N/A
FCFM N/A
ROA(3y)83.08%
ROA(5y)23.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover19.1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0.92
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z -151.3
F-Score4
WACC9.33%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)192.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2465.36%
Revenue growth 3Y90.85%
Revenue growth 5Y29.19%
Sales Q2Q%888.99%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y238.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y98.2%
OCF growth 3YN/A
OCF growth 5YN/A